Interesting commentary Systems, seems the US drug/health lobby is alive and well complete with nepotism between pharmas and FDA.
Which then leads to the question, how does little old BTA circumvent the political machine of US pharmas to receive a BARDA grant for Phase 111 Inavir studies in the the US -
If BTA does crack a substantial BARDA grant I reckon that it would be one of the first non US Biotechs to achieve same.
My guess is that the buy out of BTA by a substantial US Pharma is under way, but a what price ?
Which then leads to the question are the managament of BTA acting in shareholders interest of their own ?
(sic) Quantas as a recent example - saved at the bell by a time zone stuff up. LOL
I am hoping for a non dilutive solution and many happy dividends for years to come.
BTA Price at posting:
$1.41 Sentiment: Buy Disclosure: Held